Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5261)
All Articles published online
|
Publishing Process of This Article
|
Dec 28, 2013 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen ZT, Wu XH, Li B, Shen JS, Wang Z, Li J, Zhu XX. Nedaplatin concurrent with three-dimensional conformal radiotherapy for treatment of locally advanced esophageal carcinoma. World J Gastroenterol 2013; 19(48): 9447-9452 [PMID: 24409075 DOI: 10.3748/wjg.v19.i48.9447] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i48/9447.htm |
| Number | Citing Articles |
| 1 |
J. Chen, T. Su, Y. Lin, B. Wang, J. Li, J. Pan, C. Chen. Intensity-modulated radiotherapy combined with paclitaxel and platinum treatment regimens in locally advanced esophageal squamous cell carcinoma. Clinical and Translational Oncology 2018; 20(3): 411 doi: 10.1007/s12094-017-1734-y
|
| 2 |
Li Yin, Xiu-Hua Bian, Xue Wang, Meng Chen, Jing Wu, Jian-Hua Xu, Pu-Dong Qian, Wen-Jie Guo, Xue-Song Jiang, Huan-Feng Zhu, Jia-Jia Gu, Jian-Feng Wu, Ye-wei Zhang, Xia He, Gayle E. Woloschak. Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma. PLOS ONE 2015; 10(9): e0137383 doi: 10.1371/journal.pone.0137383
|
| 3 |
Xiaoran Yin, Jun Zhang, Xiaoning Li, Dong Liu, Cheng Feng, Rongrui Liang, Kun Zhuang, Chenlei Cai, Xinghuan Xue, Fuchun Jing, Xijing Wang, Jun Wang, Xinlian Liu, Hongbing Ma. DADS Suppresses Human Esophageal Xenograft Tumors through RAF/MEK/ERK and Mitochondria-Dependent Pathways. International Journal of Molecular Sciences 2014; 15(7): 12422 doi: 10.3390/ijms150712422
|
| 4 |
Fei Zhang, Yun Wang, Zhi-Qiang Wang, Peng Sun, De-Shen Wang, Yuan-Xue Jiang, Dong-Sheng Zhang, Feng-Hua Wang, Rui-Hua Xu, Yu-Hong Li. Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis. Diseases of the Esophagus 2016; doi: 10.1111/dote.12490
|
| 5 |
Tao Song, Xiaodong Liang, Ming Fang, Shixiu Wu. High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis. Expert Review of Anticancer Therapy 2015; 15(10): 1157 doi: 10.1586/14737140.2015.1074041
|
| 6 |
Kourosh Holakouie-Naieni, Mohammad Ali Mansournia, Amin Doosti-Irani, Abbas Rahimi-Foroushani, Peiman Haddad. Treatment-related complications in patients with esophageal cancer: A systematic review and network meta-analysis. The Surgeon 2021; 19(1): 37 doi: 10.1016/j.surge.2020.01.010
|
| 7 |
Kelun Gan, Daiyuan Ma. Hypersensitivity reaction to nedaplatin: A case report and literature review. Medicine 2023; 102(50): e36690 doi: 10.1097/MD.0000000000036690
|